Why people with diabetes can't buy generic insulin
Drug companies' incremental changes keep drugs patented, costly, Johns Hopkins study shows
(Press-News.org) Fast Facts
Drug companies have made incremental improvements that kept insulin under patent for more than 90 years.
Insulin can cost $120 to $400 per month for patients with no prescription drug coverage.
Many patients with diabetes have lapses in medication that can lead to serious complications requiring hospitalization.
A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014. As a result, say two Johns Hopkins internist-researchers, many who need insulin to control diabetes can't afford it, and some end up hospitalized with life-threatening complications, such as kidney failure and diabetic coma.
In a study published March 19, 2015, in the New England Journal of Medicine, authors Jeremy Greene, M.D., Ph.D., and Kevin Riggs, M.D., M.P.H., describe the history of insulin as an example of "evergreening," in which pharmaceutical companies make a series of improvements to important medications that extend their patents for many decades. This keeps older versions off the generic market, the authors say, because generic manufacturers have less incentive to make a version of insulin that doctors perceived as obsolete. Newer versions are somewhat better for patients who can afford them, say the authors, but those who can't suffer painful, costly complications.
"We see generic drugs as a rare success story, providing better quality at a cheaper price," says Greene, an associate professor of the history of medicine at the Johns Hopkins University School of Medicine and a practicing internist. "And we see the progression from patented drug to generic drug as almost automatic. But the history of insulin highlights the limits of generic competition as a framework for protecting the public health."
More than 20 million Americans have diabetes, in which the body fails to properly use sugar from food due to insufficient insulin, a hormone produced in the pancreas. Diabetes can often be managed without drugs or with oral medications, but some patients need daily insulin injections. The drug can often cost from $120 to $400 per month without prescription drug insurance.
"Insulin is an inconvenient medicine even for people who can afford it," says Riggs, a research fellow in general internal medicine and the Berman Institute of Bioethics at Johns Hopkins. "When people can't afford it, they often stop taking it altogether." Patients with diabetes who are not taking their prescribed insulin come to Riggs' and Greene's Baltimore-area clinics complaining of blurred vision, weight loss and intolerable thirst -- symptoms of uncontrolled diabetes, which can lead to blindness, kidney failure, gangrene and loss of limbs.
The two doctors decided to find out why no one makes generic insulin. A University of Toronto medical team discovered insulin in 1921, and in 1923, the university, which held the first patent, gave drug companies the right to manufacture it and patent any improvements. In the 1930s and 1940s, pharmaceutical companies developed long-acting forms that allowed most patients to take a single daily injection. In the 1970s and 1980s, manufacturers improved the purity of cow- and pig-extracted insulin. Since then, several companies have developed synthetic analogs.
Biotech insulin is now the standard in the U.S., the authors say. Patents on the first synthetic insulin expired in 2014, but these newer forms are harder to copy, so the unpatented versions will go through a lengthy Food and Drug Administration approval process and cost more to make. When these insulins come on the market, they may cost just 20 to 40 percent less than the patented versions, Riggs and Greene write.
ELSE PRESS RELEASES FROM THIS DATE:
Cardiometabolic risk factors, such as high blood pressure and elevated blood sugar, appear to have a bigger effect than obesity on hardening arteries early among Mexican-Americans, according to research in the Journal of the American Heart Association.
"Even among non-obese Mexican-Americans, there is already a high prevalence of clustering of cardiometabolic risk factors," said Susan T. Laing, M.D., M.Sc., lead study author and professor of cardiovascular medicine at the University of Texas Health Science Center at Houston.
"We will begin to see the impact of the high ...
MINNEAPOLIS - Researchers have developed a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia, according to a new study published in the March 18, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Our goal is to identify memory issues at the earliest possible stages," said study author Ronald C. Petersen, MD, PhD, of Mayo Clinic in Rochester, Minn., and a member of the American Academy of Neurology. "Understanding what ...
ROCHESTER, Minn - Researchers at Mayo Clinic developed a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia. The study is published in the March 18, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Our goal is to identify people who are at the highest risk for dementia as early as possible" said study author Ronald Petersen, M.D., Ph.D., Chester and Debbie Cadieux Director of the Mayo Clinic Alzheimer's Disease Research ...
Preserving isolated patches of habitat isn't enough to save species such as Bachman's Sparrow (Peucaea aestivalis) that depend on longleaf pine; habitat connectivity at the landscape level is also crucial. That is the message of a new paper by Paul Taillie, M. Nils Peterson, and Christopher Moorman of North Carolina State University, published this week in The Condor: Ornithological Applications.
In the past, fire-dependent longleaf pine forests covered vast, unbroken areas of the southeastern U.S., and Bachman's Sparrows and other species adapted to live in this expansive ...
The TRMM satellite revealed that Tropical Cyclone Nathan had powerful thunderstorms known as "hot towers" near its center which are indicative of a strengthening storm.
Cyclone Nathan is located in the Coral Sea off Australia's Queensland coast. Nathan formed on March 10 near the Queensland coast triggering warnings there before moving east. Once out at sea, Nathan made a loop and headed back to Queensland.
On March 18, Nathan was nearing the Cape York Peninsula of Queensland. As a result warnings were in effect from Cape Melville to Innisfail, extending inland to Laura. ...
Modern life, with its preponderance of inadequate exposure to natural light during the day and overexposure to artificial light at night, is not conducive to the body's natural sleep/wake cycle.
It's an emerging topic in health, one that UConn Health (University of Connecticut, Farmington, Conn.) cancer epidemiologist Richard Stevens has been studying for three decades.
"It's become clear that typical lighting is affecting our physiology," Stevens says. "But lighting can be improved. We're learning that better lighting can reduce these physiological effects. By that ...
CORAL GABLES, Fla. (March 18, 2015) -- Come spring break, college students from all over the country travel to warmer climates for time off from school and to escape the cold weather. However, it's not all fun in the sun. At popular spring break destinations, fatalities from car crashes are significantly higher during the spring break weeks compared to other times of the year, according to a recent study published in the journal Economic Inquiry.
"We found that between the last week of February and the first week of April, a significantly greater number of traffic fatalities ...
There's a carbon showdown brewing in the Arctic as Earth's climate changes. On one side, thawing permafrost could release enormous amounts of long-frozen carbon into the atmosphere. On the opposing side, as high-latitude regions warm, plants will grow more quickly, which means they'll take in more carbon from the atmosphere.
Whichever side wins will have a big impact on the carbon cycle and the planet's climate. If the balance tips in favor of permafrost-released carbon, climate change could accelerate. If the balance tips in favor of carbon-consuming plants, climate ...
In 1996, a trio of scientists won the Nobel Prize for Chemistry for their discovery of Buckminsterfullerene - soccer-ball-shaped spheres of 60 joined carbon atoms that exhibit special physical properties.
Now, 20 years later, scientists have figured out how to turn them into Buckybombs.
These nanoscale explosives show potential for use in fighting cancer, with the hope that they could one day target and eliminate cancer at the cellular level - triggering tiny explosions that kill cancer cells without affecting surrounding tissue.
"Future applications would probably ...
BLOOMINGTON, Ind. -- An Indiana University cognitive scientist and collaborators have found that posture is critical in the early stages of acquiring new knowledge.
The study, conducted by Linda Smith, a professor in the IU Bloomington College of Arts and Sciences' Department of Psychological and Brain Sciences, in collaboration with a roboticist from England and a developmental psychologist from the University of Wisconsin-Madison, offers a new approach to studying the way "objects of cognition," such as words or memories of physical objects, are tied to the position ...
LAST 30 PRESS RELEASES:
[Press-News.org] Why people with diabetes can't buy generic insulin
Drug companies' incremental changes keep drugs patented, costly, Johns Hopkins study shows